ResMed Inc. (0KW4.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 28.19B |
| Enterprise Value | 27.55B |
| P/E Ratio | 21.7 |
| PEG Ratio | 1.8 |
| Price/Sales Ratio | 5.85 |
| Price/Book Ratio | 5.73 |
| Enterprise/Revenue | 5.78 |
| Enterprise/EBITDA | 14.8 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.28 |
| Operating Margin | 0.33 |
AD
Management Effectiveness
| Return On Assets | 0.19 |
| Return On Equity | 0.25 |
Income Statement
| Revenue | 5.65B |
| Revenue/Share | 40.09 |
| Gross Profit | 3.41B |
| EBITDA | 2.16B |
| Net Income | 1.52B |
| Diluted EPS | 10.43 |
Balance Sheet
| Total Cash | 1.03B |
| Total Cash/Share | 7.07 |
| Total Debt | 610.58M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.65 |
| Book Value Per Share | 41.6 |
Price History
| 52-Week Change | -6.89 |
| 52-Week High | 277.17 |
| 52-Week Low | 180.6 |
| Moving Average 50 Days | 231.93 |
| Moving Average 200 Days | 224.35 |
Statistics
| Average Volume | 430 |
| Shares Outstanding | 142.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.52 |
| Trailing Annual Dividend Yield | 1.06 |
| Payout Ratio | 0.39 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
